← Back
$ZBIO All transactions

Zenas BioPharma, Inc.

▲ BUY
5 / 10

Conviction

$ Value

$78K

Shares

10,000

Price

$8

Filed

Apr 28

Why this score? (5/10)
  • Open market buy (+3)
  • Director (+1)
  • Not a 10b5-1 plan (+1)

Insider

Name

Xiao Ting

Title

CIK

0002035283

Roles

Director

Transaction Details

Transaction Date

2025-02-07

Code

P

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

10,000

Footnotes

The price reported is a weighted average price. These shares were purchased in multiple transactions ranging from $7.64 to $7.78, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range. | This Form 4/A is filed solely to amend the previous Form 4 filed by the Reporting Person on February 11, 2025, which incorrectly reported in column 5 of Table I the amount of securities beneficially owned following reported transactions as 47,000 shares. The correct amount of securities beneficially owned following the reported transactions is 10,000 shares.

Filing Info

Accession No.

0001104659-25-039771

Form Type

4/A

Issuer CIK

0001953926

Xiao Ting's History

Date Ticker Type Value
2025-02-07 ZBIO $78K

Other Insiders at ZBIO (90d)

Insider Bought Sold Last
Fairmount Funds Management LLC $3.0M 2026-03-31
Lu Hongbo $1.6M 2026-03-31
MOULDER LEON O JR
Chief Executive Officer
$1.0M 2026-03-31